Evaluation of FDY-5301 in Major Trauma Patients in ICU

Clinical trial NCT04430283 · TERMINATED

Trial details

NCT number: NCT04430283
Sponsor: Faraday Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

ICU Acquired Weakness

Start date: 2021-09-20
Primary completion: 2022-03-04
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.